Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.

Joris Schuurmans
Max Van Min
Chief Scientific Officer
Judith Bergboer
Chief Operating Officer
Harma Feitsma
Senior Director of Assay & Product Development
Martijn Kelder
Sales Director
Wietske Stevens
Marketing Director
Maaike Van Der Weij
Director of Quality Assurance & Regulatory Affairs
Daan de Vries
Legal Advisor

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.